BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25580906)

  • 1. Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents.
    Papadopoulou MV; Bloomer WD; Lepesheva GI; Rosenzweig HS; Kaiser M; Aguilera-Venegas B; Wilkinson SR; Chatelain E; Ioset JR
    J Med Chem; 2015 Feb; 58(3):1307-19. PubMed ID: 25580906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Kaiser M
    Eur J Med Chem; 2014 Nov; 87():79-88. PubMed ID: 25240098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Chatelain E; Kaiser M; Wilkinson SR; McKenzie C; Ioset JR
    J Med Chem; 2012 Jun; 55(11):5554-65. PubMed ID: 22550999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Ashworth R; Wilkinson SR; Kaiser M; Andriani G; Rodriguez A
    Future Med Chem; 2013 Oct; 5(15):1763-76. PubMed ID: 24144412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents.
    Papadopoulou MV; Trunz BB; Bloomer WD; McKenzie C; Wilkinson SR; Prasittichai C; Brun R; Kaiser M; Torreele E
    J Med Chem; 2011 Dec; 54(23):8214-23. PubMed ID: 22023653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Kaiser M; Chatelain E; Ioset JR
    Bioorg Med Chem; 2013 Nov; 21(21):6600-7. PubMed ID: 24012457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Szular J; Kaiser M
    Eur J Med Chem; 2016 Jul; 117():179-86. PubMed ID: 27092415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro.
    DA Silva CF; Daliry A; DA Silva PB; Akay S; Banerjee M; Farahat AA; Fisher MK; Hu L; Kumar A; Liu Z; Stephens CE; Boykin DW; Correia Soeiro MD
    Parasitology; 2011 Dec; 138(14):1863-9. PubMed ID: 21902869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-
    Menozzi CAC; França RRF; Luccas PH; Baptista MDS; Fernandes TVA; Hoelz LVB; Sales Junior PA; Murta SMF; Romanha A; Galvão BVD; Macedo MO; Goldstein ADC; Araujo-Lima CF; Felzenszwalb I; Nonato MC; Castelo-Branco FS; Boechat N
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplasmodial and antitrypanosomal activity of bicyclic amides and esters of dialkylamino acids.
    Faist J; Seebacher W; Schlapper C; Kaiser M; Brun R; Saf R; Weis R
    Bioorg Med Chem; 2009 May; 17(10):3595-603. PubMed ID: 19395265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Arylpaullones are selective antitrypanosomal agents.
    Ryczak J; Papini M; Lader A; Nasereddin A; Kopelyanskiy D; Preu L; Jaffe CL; Kunick C
    Eur J Med Chem; 2013 Jun; 64():396-400. PubMed ID: 23648975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds.
    Venkatraj M; Ariën KK; Heeres J; Joossens J; Dirié B; Lyssens S; Michiels J; Cos P; Lewi PJ; Vanham G; Maes L; Van der Veken P; Augustyns K
    Bioorg Med Chem; 2014 Oct; 22(19):5241-8. PubMed ID: 25199582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in vitro evaluation, and SAR studies of a potential antichagasic 1H-pyrazolo[3,4-b]pyridine series.
    Dias LR; Santos MB; Albuquerque Sd; Castro HC; de Souza AM; Freitas AC; DiVaio MA; Cabral LM; Rodrigues CR
    Bioorg Med Chem; 2007 Jan; 15(1):211-9. PubMed ID: 17064907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.
    Keenan M; Abbott MJ; Alexander PW; Armstrong T; Best WM; Berven B; Botero A; Chaplin JH; Charman SA; Chatelain E; von Geldern TW; Kerfoot M; Khong A; Nguyen T; McManus JD; Morizzi J; Ryan E; Scandale I; Thompson RA; Wang SZ; White KL
    J Med Chem; 2012 May; 55(9):4189-204. PubMed ID: 22536986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation.
    Cardoso MV; de Siqueira LR; da Silva EB; Costa LB; Hernandes MZ; Rabello MM; Ferreira RS; da Cruz LF; Moreira DR; Pereira VR; de Castro MC; Bernhardt PV; Leite AC
    Eur J Med Chem; 2014 Oct; 86():48-59. PubMed ID: 25147146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi.
    da Silva EN; Menna-Barreto RF; Pinto Mdo C; Silva RS; Teixeira DV; de Souza MC; De Simone CA; De Castro SL; Ferreira VF; Pinto AV
    Eur J Med Chem; 2008 Aug; 43(8):1774-80. PubMed ID: 18045742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi CYP51 inhibitor derived from a Mycobacterium tuberculosis screen hit.
    Chen CK; Doyle PS; Yermalitskaya LV; Mackey ZB; Ang KK; McKerrow JH; Podust LM
    PLoS Negl Trop Dis; 2009; 3(2):e372. PubMed ID: 19190730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro antitrypanosomal activity of novel Nifurtimox analogues.
    Pozas R; Carballo J; Castro C; Rubio J
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1417-21. PubMed ID: 15713399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of azasterols as anti-parasitics.
    Gros L; Lorente SO; Jimenez CJ; Yardley V; Rattray L; Wharton H; Little S; Croft SL; Ruiz-Perez LM; Gonzalez-Pacanowska D; Gilbert IH
    J Med Chem; 2006 Oct; 49(20):6094-103. PubMed ID: 17004723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents.
    dos Santos Filho JM; Leite AC; de Oliveira BG; Moreira DR; Lima MS; Soares MB; Leite LF
    Bioorg Med Chem; 2009 Sep; 17(18):6682-91. PubMed ID: 19683450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.